Cigarette smoking may be associated with an increased risk of systemic lupus erythematosus (SLE), but the underlying mechanism of this association remains unclear. N-acetyltransferase 2 (NAT2) is highly variable and detoxifies aromatic amines, an important class of carcinogens in tobacco smoke. Individuals who possess homozygous polymorphic alleles have a slower rate of metabolic detoxification of aromatic amines. We investigated the relationship of the NAT2 polymorphism to the risk of SLE with special reference to the interaction with cigarette smoking among 152 SLE cases and 427 controls in a female Japanese population. NAT2*4, NAT2*5B, NAT2*6A and NAT2*7B alleles were detected with polymerase chain reaction–restriction fragment length polymorphism. Individuals carrying the *4/*4 genotype are rapid acetylators, whereas those with homozygous non-*4 genotypes have a slow acetylator phenotype. Cigarette smoking was associated with an increased risk of SLE (odds ratio [OR] = 2.26; 95% confidence interval [CI] = 1.46–3.50). The slow acetylator genotype of NAT2 was significantly associated with an increased risk of SLE (OR = 2.34, 95% CI = 1.21–4.52) compared with the rapid acetylator genotype. A gene-environment interaction was suggested, with a combination of the NAT2 slow acetylator genotype and smoking conferring significantly higher risk (OR = 6.44, 95% CI = 3.07–13.52; attributable proportion due to interaction = 0.50, 95% CI = 0.12–0.88), compared with the NAT2 rapid acetylator genotype and no history of smoking. This study suggests that, in this Japanese population, the NAT2 slow acetylator status may be a determinant in susceptibility to SLE.
1 Parks CG Cooper GS . Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus2006; 15: 728–736.
2.
2 Cooper GS Dooley MA Treadwell EL St Clair EW Parks CG Gilkeson GS . Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum1998; 41: 1714–1724.
3.
3 Sanchez-Guerrero J Karlson EW Colditz GA Hunter DJ Speizer FE Liang MH . Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum1996; 39: 657–662.
4.
4 Montanaro A Bardana EJ . Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am1991; 17: 323–332.
5.
5 Costenbader KH Kim DJ Peerzada J . Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum2004; 50: 849–857.
6.
6 Washio M Horiuchi T Kiyohara C . Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females: findings from the KYSS study. Mod Rheumatol2006; 16: 143–150.
7.
7 Jarvinen P Aho K . Twin studies in rheumatic diseases. Semin Arthritis Rheum1994; 24: 19–28.
8.
8 Grennan DM Parfitt A Manolios N . Family and twin studies in systemic lupus erythematosus. Dis Markers1997; 13: 93–98.
9.
9 Deapen D Escalante A Weinrib L . A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum1992; 35: 311–318.
10.
10 Tsao BP . Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol2004; 16: 513–521.
11.
11 Hom G Graham RR Modrek B . Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med2008; 358: 900–909.
12.
12 Harley JB Alarcón-Riquelme ME Criswell LA . Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet2008; 40: 204–210.
13.
13 Remmers EF Plenge RM Lee AT . STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med2007; 357: 977–986.
14.
14 Graham RR Kyogoku C Sigurdsson S . Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci (USA)2007; 104: 6758–6763.
15.
15 Sigurdsson S Nordmark G Göring HH . Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet2005; 76: 528–537.
16.
16 Barrett JC Hansoul S Nicolae DL . Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet2008; 40: 955–962.
17.
17 Pearson TA Manolio TA . How to interpret a genome-wide association study. JAMA2008; 299: 1335–1344. Erratum in: JAMA 2008; 299: 2150.
18.
18 Perry HM Tan EM Carmody S Sakamoto A . Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. J Lab Clin Med1970; 76: 114–125.
19.
19 Woosley RL Drayer DE Reidenberg MM Nies AS Carr K Oates JA . Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med1978; 298: 1157–1159.
21 Foad B Litwin A Zimmer H Hess EV . Acetylator phenotype in systemic lupus erythematosus. Arthritis Rheum1977; 20: 815–818.
22.
22 Larsson R Karlsson E Molin L . Spontaneous systemic lupus erythematosus and acelylator phenotype. Acta Med Scand1977; 201: 223–226.
23.
23 Fishbein E Alarcón-Segovia D . Slow acetylation phenotype in systemic lupus erythematosus. Arthritis Rheum1979; 22: 95–97.
24.
24 Johansson E Mustakallio KK Mattila MJ . Polymorphic acetylator phenotype and systemic lupus erythematosus. Acta Med Scand1981; 210: 193–196.
25.
25 Reidenberg MM Martin JH . The acetylator phenotype of patients with systemic lupus erythematosus. Drug Metab Dispos1974; 2: 71–73.
26.
26 von Schmiedeberg S Fritsche E Rönnau AC . Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol1999; 455: 147–152.
27.
27 Sardas S Karakaya AE Sardas OS . Acetylator phenotype in patients with systemic lupus erythematosus. Arthritis Rheum1986; 29: 1412–1413.
28.
28 Kumana CR Chan MM Wong KL Wong RW Kou M Lauder IJ . Lack of association between slow acetylator status and spontaneous lupus erythematosus. Clin Pharmacol Ther1990; 48: 208–213.
29.
29 Ong ML Mant TG Veerapen K . The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese. Br J Rheumatol1990; 29: 462–464.
30.
30 Shiokawa S Yasuda M Nobunaga M . Genotypes of polymorphic arylamine N-acetyltransferase in systemic lupus erythematosus. Arthritis Rheum1992; 35: 1397–1399.
31.
31 Reidenberg MM Drayer DE Lorenzo B . Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum1993; 36: 971–973.
32.
32 Zschieschang P Hiepe F Gromnica-Ihle E Roots I Cascorbi I . Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosus. Pharmacogenetics2002; 12: 559–563.
33.
33 Cooper GS Treadwell EL Dooley MA St Clair EW Gilkeson GS Taylor JA . N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus. J Rheumatol2004; 31: 76–80.
34.
34 Rychlik-Sych M Skretkowicz J Gawrońska-Szklarz B Górnik W Sysa-Jedrzejowska A Skretkowicz-Szarmach K . Acetylation genotype and phenotype in patients with systemic lupus erythematosus. Pharmacol Rep2006; 58: 22–29.
35.
35 Chanock SJ Manolio T Boehnke M . NCI-NHGRI Working Group on Replication in Association Studies.Replicating genotype-phenotype associations. Nature2007; 447: 655–660.
36.
36 Khoury MJ Little J Gwinn M Ioannidis JPA . On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol2007; 36: 439–445.
37.
37 Evans DAP . N-Acetyltransferases. In: W Kalow , (ed), Pharmacogenetics of drug metabolism.New York: Pergamon Press; 1992. p. 95–197.
38.
38 Hein DW Doll MA Fretland AJ . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev2000; 9: 29–42.
39.
39 Cascorbi I Drakoulis N Brockmöller J Maurer A Sperling K Roots I . Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet1995; 57: 581–592.
40.
40 Deguchi T . Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem1992; 267: 18140–18147.
41.
41 Tan EM Cohen AS Fries JF . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
42.
42 Okumura K Kita T Chikazawa S Komada F Iwakawa S Tanigawara Y . Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism. Clin Pharmacol Ther1997; 61: 509–517.
43.
43 Kita T Tanigawara Y Chikazawa S . N-acetyltransferase 2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients. Biol Pharm Bull2001; 24: 544–549.
44.
44 Tanigawara Y Kita T Aoyama N . N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse events. Biol Pharm Bull2002; 25: 1058–1062.
45.
45 Rothman KJ . Measuring interaction. In: Epidemiology: an introduction.New York: Oxford University Press; 2002. p. 168–180.
46.
46 Andersson T Alfredsson L Källberg H Zdravkovic S Ahlbom A . Calculating measures of biological interaction. Eur J Epidemiol2005; 20: 575–579.
47.
47 Arbuckle MR McClain MT Rubertone MV . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med2003; 349: 1526–1533.
48.
48 Chowbay B Zhou S Lee EJ . An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore. Drug Metab Rev2005; 37: 327–378.
49.
49 Kumagai S Komada F Kita T . N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis. Pharm Res2004; 21: 324–329.
50.
50 Lee SY Lee KA Ki CS . Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Clin Chem2002; 48: 775–777.
51.
51 Delomenie C Sica L Grant DM Krishnamoorthy R Dupret JM . Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics1996; 6: 177–185.
52.
52 Lin HJ Han CY Lin BK Hardy S . Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: application to metabolic epidemiology. Am J Hum Genet1993; 52: 827–834.
53.
53 Saiki RK Gelfand DH Stoffel S . Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science1988; 239: 487–491.
54.
54 Haga H Yamada R Ohnishi Y Nakamura Y Tanaka T . Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet2002; 47: 605–610.
55.
55 Yamaguchi-Kabata Y Nakazono K Takahashi A . Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet2008; 83: 445–456.
56.
56 Grimaldi CM Cleary J Dagtas AS Moussai D Diamond B . Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest2002; 109: 1625–1633.
57.
57 Peeva E Michael D Cleary J Rice J Chen X Diamond B . Prolactin modulates the naive B cell repertoire. J Clin Invest2003; 111: 275–283.
58.
58 Daniel M Martin AD Faiman C . Sex hormones and adipose tissue distribution in premenopausal cigarette smokers. Int J Obes Relat Metab Disord1992; 16: 245–254.
59.
59 Key TJ Pike MC Brown JB Hermon C Allen DS Wang DY . Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br J Cancer1996; 74: 1313–1316.
60.
60 Law MR Cheng R Hackshaw AK Allaway S Hale AK . Cigarette smoking, sex hormones and bone density in women. Eur J Epidemiol1997; 13: 553–558.
61.
61 Michnovicz JJ Hershcopf RJ Naganuma H Bradlow HL Fishman J . Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med1986; 315: 1305–1309.
62.
62 Leong KH Koh ET Feng PH Boey ML . Lipid profiles in systemic lupus erythematosus. J Rheumatol1994; 21: 1264–1267.
63.
63 Burton RC . Smoking, immunity, and cancer. Med J Aust1983; 2: 411–412.
64.
64 Hersey P Prendergast D Edwards A . Effects of cigarette smoking on the immune system: follow-up studies in normal subjects after cessation of smoking. Med J Aust1983; 2: 425–429.
65.
65 Hunter DJ . Gene-environment interactions in human diseases. Nat Rev Genet2005; 6: 287–298.
66.
66 Goode EL Ulrich CM Potter JD . Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev2002; 11: 1513–1530.
67.
67 Caporaso NE . Why have we failed to find the low penetrance genetic constituents of common cancers. Cancer Epidemiol Biomarkers Prev2002; 11: 1544–1549.
68.
68 Brennan P . Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it. Carcinogenesis2002; 23: 381–387.
